The price of Rexulti (brexpiprazole) with insurance can vary significantly. Factors influencing the out-of-pocket cost include the specific insurance plan, the pharmacy, and the dosage and quantity prescribed.
How much does Rexulti cost without insurance?
Without insurance, the list price for Rexulti can be substantial. For example, a 30-day supply of 1 mg tablets might have a cash price around \$1,100 to \$1,500. A 90-day supply could cost upwards of \$3,000. These prices are subject to change and can differ between pharmacies.
Can I get a Rexulti coupon or savings card?
Yes, patients may be eligible for savings programs. The manufacturer, Otsuka Pharmaceutical, offers a Rexulti Savings Card program. This program can potentially reduce out-of-pocket costs for eligible commercially insured patients, often bringing the monthly cost down to a fixed, lower amount, such as \$10 or \$25, depending on program terms and patient eligibility. Eligibility criteria and program details can be found on the manufacturer's website.
What if my insurance doesn't cover Rexulti?
If your insurance plan does not cover Rexulti, or if your copay is too high, you may need to explore alternative options. This could include discussing alternative medications with your doctor that are covered by your insurance, or investigating patient assistance programs that might be available for uninsured or underinsured individuals. The manufacturer's savings card is primarily for commercially insured patients and may not apply if you have government insurance like Medicare or Medicaid.
How long does Rexulti take to work?
The effectiveness of Rexulti can vary among individuals. Some patients may begin to notice improvements within a few weeks of starting treatment, while for others, it may take longer to experience the full therapeutic benefits. Consistent daily use as prescribed by a healthcare provider is important for evaluating its effectiveness.
What are the common side effects of Rexulti?
Common side effects reported with Rexulti include akathisia (a feeling of inner restlessness and inability to stay still), weight gain, somnolence (drowsiness), and headache. Less common but potentially serious side effects can include movement disorders and an increased risk of death in elderly patients with dementia-related psychosis. Patients should discuss any side effects with their doctor.
How is Rexulti different from Abilify?
Rexulti (brexpiprazole) is an antipsychotic medication developed by Otsuka Pharmaceutical. It is a successor to aripiprazole (Abilify), also developed by Otsuka. While both medications work on similar dopamine and serotonin receptors in the brain, Rexulti has a slightly different receptor binding profile, which may lead to a different efficacy and side effect profile for some patients. Rexulti is indicated for the treatment of schizophrenia and as an adjunctive treatment for major depressive disorder. Abilify is also used for schizophrenia, bipolar disorder, and depression.
When does the Rexulti patent expire?
Information regarding the specific patent expiration dates for Rexulti is available through resources like DrugPatentWatch.com [1]. Patent information is complex and can involve multiple patents covering different aspects of the drug, including composition of matter, manufacturing processes, and methods of use. These patents can have different expiration dates.
Who manufactures Rexulti?
Rexulti is manufactured by Otsuka Pharmaceutical Co., Ltd.
---
Sources:
[1] DrugPatentWatch.com